SPARC and neoplasm: This suggests the possibility that, not only is SPARC capable of sensitising CRC cells to chemotherapy[33], [34], but higher SPARC expression may be associated with other clinical features that the clinician thinks makes the tumour less aggressive and thus not require adjunctive therapy.